Literature DB >> 18774185

Molecular neurobiology of bipolar disorder: a disease of 'mood-stabilizing neurons'?

Tadafumi Kato1.   

Abstract

Although the role of a genetic factor is established in bipolar disorder, causative genes or robust genetic risk factors have not been identified. Increased incidence of subcortical hyperintensity, altered calcium levels in cells derived from patients and neuroprotective effects of mood stabilizers suggest vulnerability or impaired resilience of neurons in bipolar disorder. Mitochondrial dysfunction or impaired endoplasmic reticulum stress response is suggested to play a role in the neurons' vulnerability. Progressive loss or dysfunction of 'mood-stabilizing neurons' might account for the characteristic course of the illness. The important next step in the neurobiological study of bipolar disorder is identification of the neural systems that are responsible for this disorder.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18774185     DOI: 10.1016/j.tins.2008.07.007

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  28 in total

Review 1.  Staging and neuroprogression in bipolar disorder.

Authors:  Gabriel Rodrigo Fries; Bianca Pfaffenseller; Laura Stertz; André Vinicius Contri Paz; Aroldo Ayub Dargél; Maurício Kunz; Flávio Kapczinski
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

Review 2.  Tamoxifen use for the management of mania: a review of current preclinical evidence.

Authors:  Fernanda Armani; Monica Levy Andersen; José Carlos Fernandes Galduróz
Journal:  Psychopharmacology (Berl)       Date:  2014-01-18       Impact factor: 4.530

Review 3.  Translational genomics and beyond in bipolar disorder.

Authors:  Chen Zhang; Xiao Xiao; Tao Li; Ming Li
Journal:  Mol Psychiatry       Date:  2020-05-18       Impact factor: 15.992

4.  Bax inhibitor 1, a modulator of calcium homeostasis, confers affective resilience.

Authors:  Joshua G Hunsberger; Rodrigo Machado-Vieira; Daniel R Austin; Carlos Zarate; De-Maw Chuang; Guang Chen; John C Reed; Husseini K Manji
Journal:  Brain Res       Date:  2011-06-12       Impact factor: 3.252

5.  The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder.

Authors:  Rodrigo Machado-Vieira; Natalia B Pivovarova; Ruslan I Stanika; Peixiong Yuan; Yun Wang; Rulun Zhou; Carlos A Zarate; Wayne C Drevets; Christine A Brantner; Amber Baum; Gonzalo Laje; Francis J McMahon; Guang Chen; Jing Du; Husseini K Manji; S Brian Andrews
Journal:  Biol Psychiatry       Date:  2010-12-16       Impact factor: 13.382

Review 6.  Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Authors:  Patricia J Allen
Journal:  Neurosci Biobehav Rev       Date:  2012-03-24       Impact factor: 8.989

7.  Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin.

Authors:  Anton Terasmaa; Ursel Soomets; Julia Oflijan; Marite Punapart; Mats Hansen; Vallo Matto; Kersti Ehrlich; Anne Must; Sulev Kõks; Eero Vasar
Journal:  J Physiol Biochem       Date:  2011-04-02       Impact factor: 4.158

8.  Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism.

Authors:  Jean-Michel Azorin; Charles L Bowden; Ricardo P Garay; Giulio Perugi; Eduard Vieta; Allan H Young
Journal:  Neuropsychiatr Dis Treat       Date:  2010-03-24       Impact factor: 2.570

Review 9.  Potential mechanisms of action of lithium in bipolar disorder. Current understanding.

Authors:  Gin S Malhi; Michelle Tanious; Pritha Das; Carissa M Coulston; Michael Berk
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

10.  Mood stabilizers increase prepulse inhibition in DBA/2NCrl mice.

Authors:  Dorothy G Flood; Matthew Choinski; Michael J Marino; Maciej Gasior
Journal:  Psychopharmacology (Berl)       Date:  2009-04-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.